Synergia Medical
PrivateLast Round
Series B
Extension
Jan 18, 2023
Total Funding Raised
$29.77M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Synergia Medical is a medical device company that develops next-generation, optoelectronic neurostimulation technologies for the treatment of drug-resistant epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synergia Medical Comparables
Compare Synergia Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cadence Neuroscience | 84% | |
| LivaNova | 77% | |
| NeuroPace | 72% |
Synergia Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 18, 2023 | ||||
| Grant | Oct 19, 2022 | ||||
| Series B | Sep 12, 2022 | ||||
| Accelerator | Jun 22, 2020 | ||||
| Series A | Feb 19, 2018 |
Key People
Founding team and executive leadership
Synergia Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A, Series B |
| European Innovation Council Fund | Grant |
| Newton Biocapital | Series B, Series A |
| MedTech Innovator | Accelerator |
| Société Régionale d'Investissement de Wallonie | Series A |
| Investsud | Series B, Series B Extension |
| Nivelinvest | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 88% MoM.
- Feb 1, 2025
Attila Borbath stepping down, Charles Nolet to succeed him February 1, 2025.
Synergia Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synergia Medical's valuation, stock price, and market status.
Is Synergia Medical a public or private company?
Synergia Medical is a private company.
What is the current stock price of Synergia Medical?
Synergia Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Synergia Medical worth (valuation)?
Valuation information for Synergia Medical is not publicly available.
Can I buy Synergia Medical stock?
Synergia Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synergia Medical's last funding round?
Synergia Medical's most recent funding round was Series B Extension on January 18, 2023.
Who are the main investors in Synergia Medical?
Key investors in Synergia Medical include European Innovation Council, MedTech Innovator, Société Régionale d'Investissement de Wallonie, Investsud, Nivelinvest.
Will Synergia Medical IPO soon?
No public IPO plans have been announced for Synergia Medical.
How can I track Synergia Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synergia Medical's secondary market activity and sign up for updates.